跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
马根维显 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Gadopentetic Acid Dimeglumine Salt Injection
Approved
化学药品
Gadopentetic Acid Dimeglumine Salt Injection
Bayer, Inc.
🇨🇳 National Medical Products Administration
Approval Date
Jul 5, 2021
Approval ID
8DqlhqU6OZU
Company
Bayer, Inc.
Type
化学药品
Approval Details
Approval Id
8DqlhqU6OZU
Approval Number
国药准字HJ20160598
Generic Name
钆喷酸葡胺注射液
Generic Name En
Gadopentetic Acid Dimeglumine Salt Injection
Trade Name
马根维显
Drug Type
化学药品
Dosage Form
注射剂
Strength
20ml：9.380g
Reg Date
2021-07-05
Expired Date
2026-07-04
Company Name
Bayer, Inc.
Production Company Name
BAYER AG
Company Detail Path
/organization/bayer-inc
Production Company Detail Path
/organization/bayer-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 5, 2021
Approval ID
8DqlhqU6OZU
Type
化学药品
Back to NMPA Approvals
